CE 138 Pill: orange, round
The pill with imprint CE 138 (Orange, Round, 0mm) has been identified as Imatinib Mesylate 100 mg and is used for Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Dermatofibrosarcoma Protuberans, and Gastrointestinal Stromal Tumor. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.
Images for CE 138
Imatinib Mesylate
- Imprint
- CE 138
- Strength
- 100 mg
- Color
- Orange (light orange)
- Shape
- Round (film-coated, biconvex with bevel edges)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- National Drug Code (NDC)
- 62135-0658
Related images for "CE 138"
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.